Report of Foreign Issuer (6-k)

Date : 09/14/2018 @ 9:34AM
Source : Edgar (US Regulatory)
Stock : Sanofi (PC) (SNYNF)
Quote : 89.0  0.2063 (0.23%) @ 4:28PM
Sanofi (PC) share price Chart

Report of Foreign Issuer (6-k)

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 6-K

 

 

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of September 2018

Commission File Number: 001-31368

 

 

SANOFI

(Translation of registrant’s name into English)

 

 

54, rue La Boétie, 75008 Paris, FRANCE

(Address of principal executive offices)

 

 

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F  ☒             Form 40-F  ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):  ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):  ☐

Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

Yes  ☐            No  ☒

If “Yes” marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82-             

 

 

 


In September 2018, Sanofi issued the press releases attached hereto as Exhibit 99.1 and 99.2 which are incorporated herein by reference.

Exhibit List

 

        Exhibit         
No.

  

Description

Exhibit 99.1    Press release dated September 13, 2018: Sanofi to refocus two global business units
Exhibit 99.2    Press release dated September 12, 2018: FDA to review supplemental Biologics License Application for Praluent ® (alirocumab) Injection as potential treatment to reduce major adverse cardiovascular events

 

2


Exhibit Index

 

        Exhibit         
No.

  

Description

Exhibit 99.1    Press release dated September 13, 2018: Sanofi to refocus two global business units
Exhibit 99.2    Press release dated September 12, 2018: FDA to review supplemental Biologics License Application for Praluent ® (alirocumab) Injection as potential treatment to reduce major adverse cardiovascular events

 

3


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

Dated: September 14, 2018       SANOFI
    By  

/s/ Alexandra Roger

    Name:   Alexandra Roger
    Title:   Head of Securities Law and Capital Markets

 

4

Sanofi (PC) (USOTC:SNYNF)
Historical Stock Chart

1 Year : From Nov 2017 to Nov 2018

Click Here for more Sanofi (PC) Charts.

Sanofi (PC) (USOTC:SNYNF)
Intraday Stock Chart

Today : Sunday 18 November 2018

Click Here for more Sanofi (PC) Charts.

Latest SNYNF Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:40 V:us D:20181118 05:34:32